Adding Precision Immunotherapy Improved Sepsis Outcomes

(MedPage Today) — Adding precision immunotherapy targeting macrophage activation-like syndrome and sepsis-induced immunoparalysis to standard care improved organ dysfunction by day 9 compared with standard care plus placebo, the phase IIb randomized…